Impact of KRAS mutation on response and outcome of patients with stage III non-squamous non-small cell lung cancer

The frequency and clinical profile of patients with stage III non-small cell lung cancer harboring KRAS mutations have not yet been well documented. Here, we analyzed hotspot KRAS mutations using high-resolution melting analyses in tumor specimens from patients who received chemoradiotherapy between...

Descripción completa

Detalles Bibliográficos
Autores principales: Yagishita, Shigehiro, Horinouchi, Hidehito, Sunami, Kuniko S, Kanda, Shintaro, Fujiwara, Yutaka, Nokihara, Hiroshi, Yamamoto, Noboru, Sumi, Minako, Shiraishi, Kouya, Kohno, Takashi, Furuta, Koh, Tsuta, Koji, Tamura, Tomohide, Ohe, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637997/
https://www.ncbi.nlm.nih.gov/pubmed/26177347
http://dx.doi.org/10.1111/cas.12740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637997/
https://www.ncbi.nlm.nih.gov/pubmed/26177347
http://dx.doi.org/10.1111/cas.12740

Ejemplares similares